As of 2025-11-07, the Relative Valuation of Phathom Pharmaceuticals Inc (PHAT) is (87.61) USD. This relative valuation is based on P/E multiples. With the latest stock price at 13.04 USD, the upside of Phathom Pharmaceuticals Inc based on Relative Valuation is -771.9%.
The range of the Relative Valuation is (86.19) - (90.29) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 16.0x - 19.4x | 18.4x |
| Forward P/E multiples | 18.5x - 21.2x | 19.3x |
| Fair Price | (86.19) - (90.29) | (87.61) |
| Upside | -761.0% - -792.4% | -771.9% |
| Date | P/E |
| 2025-11-05 | -2.85 |
| 2025-11-04 | -2.90 |
| 2025-11-03 | -2.95 |
| 2025-10-31 | -2.91 |
| 2025-10-30 | -2.86 |
| 2025-10-29 | -2.91 |
| 2025-10-28 | -2.91 |
| 2025-10-27 | -2.97 |
| 2025-10-24 | -2.91 |
| 2025-10-23 | -2.92 |
| 2025-10-22 | -2.89 |
| 2025-10-21 | -3.01 |
| 2025-10-20 | -3.01 |
| 2025-10-17 | -2.78 |
| 2025-10-16 | -2.86 |
| 2025-10-15 | -2.89 |
| 2025-10-14 | -2.69 |
| 2025-10-13 | -2.69 |
| 2025-10-10 | -2.54 |
| 2025-10-09 | -2.50 |
| 2025-10-08 | -2.37 |
| 2025-10-07 | -2.33 |
| 2025-10-06 | -2.49 |
| 2025-10-03 | -2.62 |
| 2025-10-02 | -2.54 |
| 2025-10-01 | -2.64 |
| 2025-09-30 | -2.53 |
| 2025-09-29 | -2.43 |
| 2025-09-26 | -2.53 |
| 2025-09-25 | -2.51 |
| 2025-09-24 | -2.52 |
| 2025-09-23 | -2.56 |
| 2025-09-22 | -2.52 |
| 2025-09-19 | -2.41 |
| 2025-09-18 | -2.52 |
| 2025-09-17 | -2.36 |
| 2025-09-16 | -2.36 |
| 2025-09-15 | -2.47 |
| 2025-09-12 | -2.54 |
| 2025-09-11 | -2.59 |
| 2025-09-10 | -2.65 |
| 2025-09-09 | -2.77 |
| 2025-09-08 | -2.67 |
| 2025-09-05 | -2.65 |
| 2025-09-04 | -2.58 |
| 2025-09-03 | -2.55 |
| 2025-09-02 | -2.55 |
| 2025-08-29 | -2.62 |
| 2025-08-28 | -2.66 |
| 2025-08-27 | -2.67 |